|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
EP1005544A4
(en)
|
1997-08-19 |
2004-07-14 |
Human Genome Sciences Inc |
70 HUMAN, SECRETED PROTEINS
|
|
EP1012179A2
(en)
|
1997-09-12 |
2000-06-28 |
Apotech R&D S.A. |
Cysteine rich receptors: trail
|
|
EP1015488B1
(en)
*
|
1997-09-17 |
2009-09-09 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
|
US6849719B2
(en)
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
|
US20030039648A1
(en)
|
1998-09-16 |
2003-02-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
ES2292242T5
(es)
|
1998-05-15 |
2011-05-04 |
Genentech, Inc. |
Utilizaciones terapéuticas de polipéptidos homólogos de il-17.
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US20030009013A1
(en)
|
1998-12-30 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6291663B1
(en)
*
|
1999-03-03 |
2001-09-18 |
Board Of Trustees Of The University Of Arkansas |
TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
|
|
US8133734B2
(en)
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
|
EP2336321A1
(en)
*
|
1999-05-13 |
2011-06-22 |
Medical Research Council |
Ox2 receptor homolog
|
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1621620A3
(en)
*
|
1999-09-01 |
2006-05-10 |
Genetech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU784746B2
(en)
|
1999-11-18 |
2006-06-08 |
Dendreon Corporation |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
DK1897944T3
(da)
*
|
1999-12-23 |
2011-10-24 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutisk anvendelse deraf
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
US20020155499A1
(en)
*
|
2000-09-25 |
2002-10-24 |
Leiby Kevin R. |
32624, a novel human UDP-glucuronosyl and glycosyl transferase family member and uses thereof
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
EP1280923A2
(en)
*
|
2000-04-28 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
14094, a human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6965018B2
(en)
|
2000-06-06 |
2005-11-15 |
Bristol-Myers Squibb Company |
Antibodies directed to B7-related polypeptide, BSL-2
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
AU2001268440A1
(en)
*
|
2000-06-15 |
2002-01-08 |
Millennium Pharmaceuticals, Inc. |
53320, a human acyltransferase and uses therefor
|
|
EP1297133A2
(en)
*
|
2000-06-22 |
2003-04-02 |
Biogen, Inc. |
Gp354 nucleic acids and polypeptides
|
|
AU2001273194A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Amgen Inc. |
B7-Like Molecules and Uses Thereof
|
|
WO2002010217A2
(en)
|
2000-08-02 |
2002-02-07 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
|
AU2001229503A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
|
WO2002020800A2
(en)
*
|
2000-09-01 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
16658, 14223, and 16002, NOVEL HUMAN KINASES AND USES THEREFOR
|
|
EP1334179A2
(en)
|
2000-11-14 |
2003-08-13 |
Bristol-Myers Squibb Company |
A human serpin secreted from lymphoid cells lsi-01
|
|
DE10106835A1
(de)
*
|
2001-02-14 |
2002-09-05 |
Basf Lynx Bioscience Ag |
Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen
|
|
WO2002064769A1
(en)
*
|
2001-02-15 |
2002-08-22 |
Shionogi & Co., Ltd. |
Novel disease marker
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
CA2440618A1
(en)
*
|
2001-03-12 |
2002-09-19 |
Incyte Genomics, Inc. |
Immunoglobulin superfamily proteins
|
|
US7125703B2
(en)
|
2001-03-13 |
2006-10-24 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
US7172892B2
(en)
|
2001-03-22 |
2007-02-06 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
|
|
JP2005506047A
(ja)
|
2001-03-27 |
2005-03-03 |
デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー |
膜貫通型セリンプロテアーゼ９をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法
|
|
US7033790B2
(en)
|
2001-04-03 |
2006-04-25 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
EP1573024A4
(en)
|
2001-04-10 |
2007-08-29 |
Agensys Inc |
NUCLEIC ACIDS AND SUITABLE PROTEINS SUITABLE FOR THE TREATMENT AND EVIDENCE OF VARIOUS CANCER DISEASES
|
|
AU2002258780A1
(en)
|
2001-04-11 |
2002-10-28 |
Bristol-Myers Squibb Company |
Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
|
|
US7112430B2
(en)
|
2001-05-14 |
2006-09-26 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
JP4224395B2
(ja)
*
|
2001-06-22 |
2009-02-12 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
ＰａｎＣＡＭ核酸およびポリペプチド
|
|
WO2003004530A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human somatostatin receptor-like protein
|
|
EP1436392A2
(en)
*
|
2001-07-26 |
2004-07-14 |
Genset S.A. |
Gmg-2 polynucleotides and polypeptides and uses thereof
|
|
JP4702819B2
(ja)
*
|
2001-08-01 |
2011-06-15 |
生化学工業株式会社 |
コンドロイチン合成酵素
|
|
JP4102898B2
(ja)
*
|
2001-08-23 |
2008-06-18 |
独立行政法人科学技術振興機構 |
造血幹細胞増殖調節因子及びそれをコードするポリヌクレオチド
|
|
NZ573739A
(en)
*
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly colorectal tumor - TAT201
|
|
WO2003025162A2
(en)
*
|
2001-09-20 |
2003-03-27 |
Bayer Healthcare Ag |
Regulation of human prolyl 4-hydroxylase alpha subunit precursor
|
|
JP2005508171A
(ja)
*
|
2001-11-02 |
2005-03-31 |
タノックス インコーポレーテッド |
Ｂ細胞悪性病変の診断及び予防に用いるためのｂ細胞リンパ腫特異抗原
|
|
AU2002359815A1
(en)
|
2001-12-19 |
2003-07-09 |
Immunex Corporation |
C-type lectin polypeptide, polynucleotide and methods of making and use thereof
|
|
DE10211088A1
(de)
*
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
KR20040111525A
(ko)
*
|
2002-04-17 |
2004-12-31 |
제넨테크, 인크. |
종양의 진단 및 치료 방법 및 이를 위한 조성물
|
|
EP2275118A3
(en)
|
2002-05-29 |
2011-10-19 |
DeveloGen Aktiengesellschaft |
Pancreas-specific proteins
|
|
US7232676B2
(en)
*
|
2002-05-31 |
2007-06-19 |
Seikagaku Kogyo Kabushiki Kaisha |
Chondroitin synthase and nucleic acid encoding the enzyme
|
|
AU2003241979A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Hidetoshi Inoko |
Inflammatory skin disease-related slurp-2 gene and utilization thereof
|
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
DE10242016A1
(de)
*
|
2002-09-11 |
2004-03-25 |
Esplora GmbH c/o TU Darmstadt Institut für Biochemie |
Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon
|
|
JP2006518582A
(ja)
*
|
2002-09-11 |
2006-08-17 |
ジェネンテック・インコーポレーテッド |
乾癬の治療のための新規組成物と方法
|
|
DE10254601A1
(de)
*
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
AU2003292774A1
(en)
*
|
2002-12-26 |
2004-07-22 |
Takeda Pharmaceutical Company Limited |
Novel proteins and use thereof
|
|
AU2003302753A1
(en)
*
|
2002-12-27 |
2004-08-10 |
Laboratoires Serono Sa |
Novel fibrillin-like polypeptides
|
|
EP1588167A4
(en)
*
|
2003-01-16 |
2006-08-09 |
Univ Virginia |
SPERM-SPECIFIC LYSOCYLUM PROTEINS
|
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
DK1641822T3
(da)
|
2003-07-08 |
2013-07-22 |
Genentech Inc |
Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
|
|
EP1660537A2
(en)
|
2003-08-14 |
2006-05-31 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
US7825235B2
(en)
|
2003-08-18 |
2010-11-02 |
Isis Pharmaceuticals, Inc. |
Modulation of diacylglycerol acyltransferase 2 expression
|
|
WO2005061704A1
(ja)
*
|
2003-12-24 |
2005-07-07 |
Takeda Pharmaceutical Company Limited |
癌の予防・治療剤
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
RU2007104022A
(ru)
|
2004-07-02 |
2008-08-10 |
Дженентек, Инк. (Us) |
Композиции для лечения неходжкинской лимфомы и способы их применения
|
|
EP1789070B1
(en)
|
2004-08-03 |
2012-10-24 |
Biogen Idec MA Inc. |
Taj in neuronal function
|
|
ES2414460T3
(es)
|
2004-08-04 |
2013-07-19 |
Amgen Inc. |
Anticuerpos para Dkk-1
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
AU2006223579A1
(en)
*
|
2005-03-11 |
2006-09-21 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
US8609816B2
(en)
|
2005-12-08 |
2013-12-17 |
Medarex, L.L.C. |
Human monoclonal antibodies to O8E
|
|
WO2007107774A2
(en)
*
|
2006-03-22 |
2007-09-27 |
Cartela R & D Ab |
Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
|
|
CA2649387A1
(en)
*
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
ES2397661T3
(es)
|
2006-08-04 |
2013-03-08 |
Isis Pharmaceuticals, Inc. |
Composiciones y sus usos dirigidos a la diacilglicerol aciltransferasa 1
|
|
EP2069793B9
(en)
|
2006-08-29 |
2017-08-16 |
Oxford BioTherapeutics Ltd |
Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
|
|
WO2008042826A2
(en)
|
2006-09-29 |
2008-04-10 |
University Of Maryland, Baltimore |
Use of omentin 1 and omentin 2 in the diagnosis and treatment of disease
|
|
BRPI0908312A2
(pt)
|
2008-05-05 |
2015-08-18 |
Novimmune Sa |
'' anticorpo monoclonal totalmente humano isolado, composição farmacêutica, método de alívio de um sintoma de uma indicação clínica e método de alívio de um sintoma de uma doença autoimune, distúrbio inflamatório ou distúrbio da proliferação celular''
|
|
CA2726804C
(en)
|
2008-06-02 |
2021-12-28 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1 peptides
|
|
JP5816558B2
(ja)
|
2009-03-05 |
2015-11-18 |
メダレックス・リミテッド・ライアビリティ・カンパニーＭｅｄａｒｅｘ， Ｌ．Ｌ．Ｃ． |
Ｃａｄｍ１に特異的な完全ヒト抗体
|
|
EP2427203B1
(en)
|
2009-05-05 |
2018-10-17 |
Novimmune S.A. |
Anti-il-17f antibodies and use thereof
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
JP6374392B2
(ja)
|
2012-11-05 |
2018-08-15 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
Ｘｂｐ１、ｃｄ１３８およびｃｓ１ペプチド、該ペプチドを含有する薬学的組成物、ならびにかかるペプチドおよび組成物を使用する方法
|
|
IL282953B2
(en)
|
2012-11-13 |
2026-02-01 |
Tron Translationale Onkologie An Der Johannes Gutenberg Univ Mainz Gemeinnutzige Gmbh |
Agents for the treatment of claudin-expressing cancers
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
CA2991894A1
(en)
|
2015-07-10 |
2017-01-19 |
Ionis Pharmaceuticals, Inc. |
Modulators of diacyglycerol acyltransferase 2 (dgat2)
|